1. Carcinomatosis under control by osimertinib in EGFR and TP53 mutated lung adenocarcinoma. Issue 6 (December 2021) Authors: Provenzano, Leonardo; Cuccarini, Valeria; Platania, Marco; Canziani, Luca; Spagnoletti, Andrea; Doniselli, Fabio M.; Eoli, Marica; Prelaj, Arsela; Anghileri, Elena Journal: Tumori Issue: Volume 107:Issue 6(2021) Page Start: NP136 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. CLRM-08 TARGETING IMMUNE-PAYLOAD TO THE GLIOBLASTOMA TUMOR MICROENVIRONMENT USING A MACROPHAGE-BASED TREATMENT RELYING ON AUTOLOGOUS, GENETICALLY MODIFIED, HEMATOPOIETIC STEM CELL-BASED THERAPY: THE TEM-GBM STUDY (NCT03866109). (5th August 2022) Authors: Eoli, Marica; Farina, Francesca; Gentner, Bernhard; Capotondo, Alessia; Anghileri, Elena; Barcella, Matteo; Brambilla, Valentina; Bruzzone, Maria Grazia; Carrabba, Matteo; Cuccarini, Valeria; d'Alessandris, Giorgio; Meco, Francesco Di; Ferla, Valeria; Franzin, Alberto; Ferroli, Paolo; Gagliardi, ... Journal: Neuro-oncology advances Issue: Volume 4(2022)Supplement 1 Page Start: i7 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. CTIM-24. AUTOLOGOUS CD34+ ENRICHED HEMATOPOIETIC PROGENITOR CELLS GENETICALLY MODIFIED FOR HUMAN INTERFERON-α2, ARE WELL TOLERATED & RAPIDLY ENGRAFT IN PATIENTS WITH GLIOBLASTOMA MULTIFORME (TEM-GBM_001 STUDY). (9th November 2020) Authors: Finocchiaro, Gaetano; Gentner, Bernhard; Eoli, Marica; Francesca, Farina; Anghileri, Elena; Girlanda, Stefania; Carrabba, Matteo; Cuccarini, Valeria; DiMeco, Francesco; Legnani, Federico; Pollo, Bianca; Bruzzone, Maria Grazia; Saini, Marco; Ferroli, Paolo; Capotondo, Alessia; Paterra, Rosina; Gar... Journal: Neuro-oncology Issue: Volume 22(2020)Supplement 2 Page Start: ii38 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. EPCO-02. GENOME-WIDE DNA METHYLATION PROFILING AND GENETIC CHARACTERIZATION OF LONG-TERM SURVIVAL IDH WILD-TYPE GLIOBLASTOMA PATIENTS. (14th November 2022) Authors: Miele, Evelina; Lazzarini, Elisabetta; Ciolfi, Andrea; Pedace, Lucia; Nardini, Claudia; Patrizi, Sara; Mastronuzzi, Angela; Tartaglia, Marco; Anghileri, Elena; Calatozzolo, Chiara; Lamperti, Elena Antonia; Patanè, Monica; Locatelli, Franco; Indraccolo, Stefano; Pollo, Bianca Journal: Neuro-oncology Issue: Volume 24(2022)Supplement 7 Page Start: vii115 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Expansion of effector and memory T cells is associated with increased survival in recurrent glioblastomas treated with dendritic cell immunotherapy. Issue 1 (20th August 2019) Authors: Eoli, Marica; Corbetta, Cristina; Anghileri, Elena; Di Ianni, Natalia; Milani, Micaela; Cuccarini, Valeria; Musio, Silvia; Paterra, Rosina; Frigerio, Simona; Nava, Sara; Lisini, Daniela; Pessina, Sara; Maddaloni, Luisa; Lombardi, Raffaella; Tardini, Maria; Ferroli, Paolo; DiMeco, Francesco; Bruzz... Journal: Neuro-oncology advances Issue: Volume 1:Issue 1(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. IMMU-01. TEM-GBM: AN OPEN-LABEL, PHASE I/IIA DOSE-ESCALATION STUDY EVALUATING THE SAFETY AND EFFICACY OF GENETICALLY MODIFIED TIE-2 EXPRESSING MONOCYTES TO DELIVER IFN-A WITHIN GLIOBLASTOMA TUMOR MICROENVIRONMENT. (21st September 2021) Authors: Finocchiaro, Gaetano; Eoli, Marica; Gentner, Bernhard; Capotondo, Alessia; Anghileri, Elena; Antonarelli, Gabriele; Barcella, Matteo; Bruzzone, Maria Grazia; Carrabba, Matteo; Cuccarini, Valeria; D'Alessandris, Quintino G; DiMeco, Francesco; Farina, Francesca; Ferla, Valeria; Ferroli, Paolo; Gagl... Journal: Neuro-oncology advances Issue: Volume 3(2021)Supplement 4 Page Start: iv4 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. MYD88 L265P mutation and interleukin‐10 detection in cerebrospinal fluid are highly specific discriminating markers in patients with primary central nervous system lymphoma: results from a prospective study. (23rd February 2021) Authors: Ferreri, Andrés J. M.; Calimeri, Teresa; Lopedote, Paolo; Francaviglia, Ilaria; Daverio, Rita; Iacona, Chiara; Belloni, Cristina; Steffanoni, Sara; Gulino, Alessandro; Anghileri, Elena; Diffidenti, Angelo; Finardi, Annamaria; Gagliardi, Filippo; Anzalone, Nicoletta; Nonis, Alessandro; Furlan, Rob... Journal: British journal of haematology Issue: Volume 193:Number 3(2021) Page Start: 497 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Survival gain in glioblastoma patients treated with dendritic cell immunotherapy is associated with increased NK but not CD8+ T cell activation in the presence of adjuvant temozolomide. (3rd April 2018) Authors: Pellegatta, Serena; Eoli, Marica; Cuccarini, Valeria; Anghileri, Elena; Pollo, Bianca; Pessina, Sara; Frigerio, Simona; Servida, Maura; Cuppini, Lucia; Antozzi, Carlo; Cuzzubbo, Stefania; Corbetta, Cristina; Paterra, Rosina; Acerbi, Francesco; Ferroli, Paolo; DiMeco, Francesco; Fariselli, Laura; ... Journal: Oncoimmunology Issue: Volume 7:Number 4(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗